Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001548123-12-000028
Filing Date
2012-05-09
Accepted
2012-05-09 11:51:12
Documents
10
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ON FORM 10Q FOR THE QUARTER ENDED MARCH 31, 2012 skin_12q1final.htm 10-Q 145466
2 PRINCIPAL EXECUTIVE OFFICER CERTIFICATION ex311.htm EX-31 6069
3 PRINCIPAL FINANCIAL OFFICER CERTIFICATION ex312.htm EX-31 5906
4 SECTION 1350 CERTIFICATION ex32.htm EX-32 2826
  Complete submission text file 0001548123-12-000028.txt   699710

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT skin-20120331.xml EX-101.INS 25386
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT skin-20120331_pre.xml EX-101.PRE 43584
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT skin-20120331_lab.xml EX-101.LAB 58073
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT skin-20120331_def.xml EX-101.DEF 34815
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT skin-20120331_cal.xml EX-101.CAL 17418
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT skin-20120331.xsd EX-101.SCH 8073
Mailing Address 2157 S. LINCOLN ST SALT LAKE CITY UT 84106
Business Address 2157 S. LINCOLN ST SALT LAKE CITY UT 84106 8013232395
SKINOVATION PHARMACEUTICAL INC (Filer) CIK: 0001118072 (see all company filings)

EIN.: 870458170 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30991 | Film No.: 12824498
SIC: 6770 Blank Checks